Group 1 - The company *ST Asia Pacific (000691.SZ) expects a net loss of between 51.46 million to 28.39 million yuan for 2025, with a non-recurring net loss projected between 43.95 million to 24.25 million yuan, and operating revenue estimated to be between 416.80 million to 599.15 million yuan [1] - The increase in operating revenue and net profit compared to the same period last year is primarily attributed to the recovery of the industry cycle and the rebound in demand for pesticides and pharmaceutical intermediates [1] - The equity attributable to shareholders of the listed company has significantly increased compared to the same period last year, mainly due to the completion of bankruptcy reorganization, receipt of reorganization investment funds, debt exemptions, and cash donations [1]
*ST亚太(000691.SZ):预计2025年净亏损2839.07万元-5145.81万元